(Q24815871)

English

Subcutaneously administered Menopur, a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex in subjects undergoing in vitro fertilization

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Subcutaneously administered Menopur, a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex in subjects undergoing in vitro fertilization (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

reproductive medicine

0 references

author name string

William R Keye

1

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Bobby Webster

2

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Richard Dickey

3

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Stephen Somkuti

4

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Jack Crain

5

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

M Joseph Scobey

6

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

language of work or name

0 references

publication date

9 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Reproductive Biology and Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

1

0 references

62

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Prion transmission in blood and urine: what are the implications for recombinant and urinary-derived gonadotrophins?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309620

7 April 2017

Historical perspectives in gonadotrophin therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309620

28 September 2017

Clinical effect of human pituitary follicle-stimulating hormone (FSH).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309620

28 September 2017

Batch-to-batch consistency of human-derived gonadotrophin preparations compared with recombinant preparations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309620

28 November 2018

Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309620

28 November 2018

Identifiers

10.1186/1477-7827-3-62

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1477-7827-3-62

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24815871&oldid=2177043899"